Form 4: HealthEquity EVP Sells Shares for Tax Obligations

HealthEquity's EVP and General Counsel, Delano Ladd, reported a planned disposition of 739 common shares for tax liabilities under a 10b5-1 plan.

Summary

• Delano Ladd, Executive Vice President and General Counsel of HealthEquity, Inc. (HQY), reported a transaction involving the company's common stock.
• The transaction, dated January 9, 2026, involved the disposition of 739 shares.
• The shares were disposed of to cover tax liabilities, indicated by transaction code "F".
• The weighted average price per share for the disposition was $95.237, with individual transactions ranging from $95.2363 to $95.2379.
• Following this transaction, Delano Ladd beneficially owns 73,240 shares of HealthEquity common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction (disposition for tax liability) under a 10b5-1 plan. Such transactions are generally neutral in sentiment as they are often administrative rather than indicative of management's view on the company's future prospects. The unusual future transaction date is noted but does not inherently change the neutral sentiment of a tax-related sale.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, which indicates a pre-arranged, non-discretionary sale, often used by insiders to avoid accusations of trading on material non-public information.

Negatives

• The disposition of shares by an executive reduces their direct ownership stake in the company.
• The transaction date of January 9, 2026, is in the future, which is unusual for a Form 4 filing that typically reports completed transactions.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance. It reports a specific insider transaction.

Industry Context

Insider transactions, particularly those related to tax obligations (Code F), are common occurrences across all industries, especially for executives receiving equity compensation. The use of a 10b5-1 plan is a standard practice for managing such transactions in a compliant manner.

Comparison to Industry Standards

• The disposition of shares to cover tax liabilities upon vesting of equity awards is a standard practice for executives across publicly traded companies, aligning with typical executive compensation structures.
• The use of a Rule 10b5-1 plan for such transactions is considered a best practice in corporate governance, demonstrating a pre-planned, non-discretionary approach to insider trading.

Corporate Governance

Related Party Transactions

• The reported transaction is an insider sale by an executive, which is a form of related party transaction, but it's a routine disposition for tax purposes rather than a complex dealing.

Stakeholder Impact

• Shareholders: Minimal direct impact. A small reduction in an executive's direct ownership, but the transaction is routine and pre-planned.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.

Key Dates

Keywords

HealthEquity, HQY, Delano Ladd, Insider Trading, Form 4, Stock Sale, Tax Liability, 10b5-1 Plan, Executive Compensation, Common Stock